AKAN — Akanda Corp.

Is AKAN overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Drug Manufacturers - Specialty & Generic

Strong Oversold As of July 5, 2026

Akanda Corp. (AKAN) currently reads Strong Oversold on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Drug Manufacturers - Specialty & Generic) last closed at $12.33. The rating moved from Overbought to Strong Oversold on June 23, 2026 and has changed 12 times in the last 90 days.

Public ratingStrong Oversold (as of July 5, 2026)
Last close$12.33
Rating changesRating changed 12 times in the last 90 days
Last changeMoved from Overbought to Strong Oversold on June 23, 2026
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Latest MarketMoodz coverage

Kulicke & Soffa Surges 19% Premarket on Q2 Beat2026-05-07

See today's live rating, score and targets

Members see the live hourly rating for AKAN — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.